Ozempic Eye Side Effects

Common side effects of Ozempic are mostly gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal pain. Recently, however, people have also reported problems with their eyes. Some users have noticed blurry vision, dry eyes, and the phrase “Ozempic blindness” has started to appear online.

This article looks at the different eye problems reported by patients taking Ozempic and explores the possible reasons behind them.

6 Ozempic Eye Side Effects Reported By Patients

Here’s a concise, evidence-based rundown of eye problems people have reported while using Ozempic:

1. Temporary blurred vision or “vision fluctuations”

Some patients have reported experiencing blurry or shifting vision shortly after starting Ozempic or when doses change.

In a post, a user shared that they had started Ozempic about five weeks earlier and recently increased their dose. After about two to three weeks on the medication, they began experiencing blurry vision. Despite visits to urgent care, the ER, and calls to nurse hotlines, no issues were found. Their diabetic eye exam a month prior was normal.

They explained that their blood sugar had dropped significantly since starting treatment, previously as high as 550, now ranging between 117-300. While the medication was working for blood sugar, they were very frustrated, crying at work because their job required long hours on a screen, and the vision changes and headaches were unbearable.

This is actually a common effect in diabetes. When blood sugar control improves quickly, the lens hydration and thickness of the eye can change. This briefly shifts refraction, sometimes making it more farsighted, sometimes more nearsighted. Vision usually goes back to normal once blood sugar levels stay steady for a few days to weeks.

In one study, researchers wanted to see how controlling blood sugar affects vision changes in people with diabetes. All patients became more farsighted after starting insulin. On average, vision shifted by about +1.60 diopters, some as little as +0.50, some as much as +3.20.

Their eyesight returned to normal within 2-4 weeks of treatment.

Researchers observed that people with higher HbA1c at the start tended to have greater vision changes. They also found that when blood sugar dropped more rapidly in the first week, the temporary shift toward farsightedness was stronger.

Other eye parameters (eye pressure, corneal shape, lens thickness, etc.) did not change significantly. This suggests the vision change came from shifts in the lens’ refractive index, not from physical changes in eye size or shape.

2. Early worsening of diabetic retinopathy

Diabetic retinopathy (DR) is a very common complication of diabetes. It damages the small blood vessels in the retina, the light-sensitive layer at the back of the eye. Over time, high blood sugar weakens these vessels, leading to leakage, swelling, or abnormal new vessel growth.

According to statistics, DR affects an estimated 77.3% of individuals with type 1 diabetes and 25.1% of those with type 2 diabetes. Of these patients, up to 30% will progress to vision-threatening diabetic macular edema (DME).

A paradoxical effect known as early worsening can occur when blood sugar levels improve quickly after being poorly controlled. This was first observed in the 1980s among patients with type 1 diabetes who switched from standard insulin regimens to intensive therapy. In some of these patients, existing retinopathy advanced rapidly within 3-6 months.

Ozempic is highly effective at lowering blood glucose, which means patients with pre-existing retinopathy may be at risk of early worsening. For this reason, Ozempic carries a precaution to monitor patients with DR complications during treatment.

Evidence from a 2-year clinical trial in people with type 2 diabetes and high cardiovascular risk highlights this risk. In the trial:

The risk of DR getting worse is higher if someone has had diabetes for a long time, keeps poor blood sugar control, or has uncontrolled high blood pressure.

3. Non-arteritic anterior ischemic optic neuropathy (NAION)

Doctors have reported cases of NAION, a sudden and irreversible form of vision loss, in people using Ozempic.

One case involved a 60-year-old man with long-standing type 2 diabetes and several health conditions, including:

• • hypertension
  • high cholesterol
  • obesity
  • sleep apnea
  • prior heart disease

He had been on Ozempic for five years and suddenly lost vision in one eye. However, it’s inconclusive if the drug itself was responsible or the effect is due to the patient’s underlying conditions.

Large studies have also tried to clarify the link:

Experts point out that many people prescribed GLP-1 drugs already have conditions like hypertension, advanced diabetes, or sleep apnea, all of which increase NAION risk on their own.

Despite the uncertainty, global health agencies such as the WHO and EMA have raised concerns about this risk. In response, the EMA has recommended updating the safety information for semaglutide products (Ozempic, Wegovy, Rybelsus) to include it as an adverse effect.

4. Neovascular age-related macular degeneration (nAMD)

The most recent reports of eye side effects from Ozempic involve neovascular age-related macular degeneration (nAMD). This condition is caused by abnormal blood vessel growth in the retina. These fragile vessels can leak fluid or blood, leading to swelling, scarring, and often rapid vision loss.

Common symptoms include:

• • blurred or distorted central vision
  • straight lines appearing wavy
  • a dark or empty spot in the center of vision
  • sudden worsening of vision

A retrospective cohort study followed more than 138,000 patients with diabetes aged 66 or older for three years. Of these, 46,334 had used a GLP-1 receptor agonist (almost all semaglutide) and 92,668 had never used one.

Within three years, 0.2% of GLP-1 RA users developed nAMD, compared with 0.1% of non-users. After adjusting for other factors, GLP-1 RA use was linked to a 2.21 times higher risk of developing nAMD.

This finding suggests a possible connection between semaglutide and new cases of nAMD, but it does not prove causation.

5. Dry-eye symptoms

A forum user reported that after increasing their Ozempic dose to 1.0 mg, they developed painful dry eyes that worsened over the week. They also experienced severe dry mouth. Even with more than two liters of water a day, electrolytes, and over-the-counter eye drops, the dryness continued. Their eyes felt heavy and tired, and they asked if others had similar experiences.

This type of eye discomfort, often described as dryness, grittiness, or irritation, may not be caused directly by Ozempic but can be explained by several factors:

6. Neuro-ophthalmic presentations

Neuro-ophthalmic presentations often signal underlying systemic or neurological disease, including stroke, multiple sclerosis, brain tumors, aneurysms, or giant cell arteritis. Because of this, accurate diagnosis and treatment usually require collaboration between ophthalmologists and neurologists.

A recent case report described such a presentation in connection with oral semaglutide (Rybelsus) rather than Ozempic. A 72-year-old man began high-dose oral semaglutide (3.0 mg daily) for weight loss. Seventeen days later, he noticed a small central blind spot (scotoma) in his right eye that gradually enlarged, followed two days later by a similar spot in his left eye.

The blind spots were present only under low-light (scotopic) conditions, not in daylight or normal room lighting. After noticing symptoms in the second eye, he stopped taking semaglutide. Within two days, all symptoms completely resolved.

This case represents the first published report of bilateral central scotomas associated with semaglutide use. However, the exact mechanism remains unknown.

What to Do if You Notice Eye Symptoms While Taking Ozempic

Your eyes are one of the most sensitive organs in your body, and vision loss can be permanent if not addressed quickly. Here’s how to protect yourself:

Bottom line

Not all eye problems seen with Ozempic are directly caused by the drug. Some stem from rapid drops in blood sugar, while rare reports like NAION or nAMD remain uncertain and lack solid proof of causation.

For most people, eye problems never develop. But if you already have diabetic eye disease, you must get checked before and shortly after starting. And if you notice sudden changes in your vision, don’t wait, see an eye doctor right away.

Frequently Asked Questions